Subscribe
Home
Issues
Online First
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
Value-Based Care in Myeloma
Articles
Articles
Bevacizumab plus Chemotherapy Approved for Several Types of Ovarian Cancer
FDA Approvals, News & Updates
August 2018, Vol 9, No 2 | Payers’ Perspectives In Oncology: ASCO
Read More
Keytruda Receives 2 New Indications: Metastatic Cervical Cancer and Relapsed Mediastinal Large B-Cell Lymphoma
FDA Approvals, News & Updates
August 2018, Vol 9, No 2 | Payers’ Perspectives In Oncology: ASCO
Read More
Venclexta Indicated for CLL or SLL, Alone or in Combination with Rituxan
FDA Approvals, News & Updates
August 2018, Vol 9, No 2 | Payers’ Perspectives In Oncology: ASCO
Read More
Tafinlar-Mekinist Combination Approved for Metastatic Thyroid Cancer with BRAF V600E Mutation
FDA Approvals, News & Updates
August 2018, Vol 9, No 2 | Payers’ Perspectives In Oncology: ASCO
Read More
Kymriah Approved for Adults with Relapsed or Refractory Large B-Cell Lymphoma
FDA Approvals, News & Updates
August 2018, Vol 9, No 2 | Payers’ Perspectives In Oncology: ASCO
Read More
Pomalidomide Added to the Regimen in First Relapse Extends PFS in Multiple Myeloma
By
Wayne Kuznar
Clinical Trials
,
Multiple Myeloma
,
Hematologic Malignancies
,
Personalized Medicine
August 2018, Vol 9, No 2 | Payers’ Perspectives In Oncology: ASCO
Read More
Nelarabine Therapy Up Front Boosts Survival in T-Cell Leukemia and Lymphoma
By
Phoebe Starr
Hematologic Malignancies
,
Leukemia
August 2018, Vol 9, No 2 | Payers’ Perspectives In Oncology: ASCO
Read More
Next-Generation Sequencing Could Help Treatment Decisions in Acute Myeloid Leukemia
By
Chase Doyle
Leukemia
,
Hematologic Malignancies
August 2018, Vol 9, No 2 | Payers’ Perspectives In Oncology: ASCO
Read More
Timing of Palliative Care Consults Affects Healthcare Utilization in Elderly Patients with Pancreatic Cancer
By
Chase Doyle
Pancreatic Cancer
August 2018, Vol 9, No 2 | Payers’ Perspectives In Oncology: ASCO
Read More
High Tumor Microsatellite Instability a Marker for Lynch Syndrome, More Common Condition Than Generally Expected
By
Wayne Kuznar
Lynch Syndrome
August 2018, Vol 9, No 2 | Payers’ Perspectives In Oncology: ASCO
Based on results of a study presented at ASCO 2018, the presence of an MSI-H or dMMR tumor signature, regardless of cancer type or family history, should prompt genetic testing to evaluate for Lynch syndrome.
Read More
Page 111 of 330
108
109
110
111
112
113
114
Top Trending Articles
1.
FDA Approves Acalabrutinib and Venetoclax Combination for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
2.
FDA Grants Traditional Approval to Selpercatinib for Locally Advanced or Metastatic RET Fusion-Positive Solid Tumors
3.
FDA Launches Unified Adverse Event Monitoring System to Enhance Transparency and Efficiency
Home
Issues
Online First
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
Value-Based Care in Myeloma